证券代码：688108 证券简称：赛诺医疗 公告编号：2025-047 赛诺医疗科学技术股份有限公司 关于股东解除一致行动关系的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 2022 年 12 月，公司上市满 3 年后，阳光德业、阳光永业、阳光广业、阳光福业分别 本次公司股东解除一致行动关系事项，符合《公司法》《证券法》《上市公司收购管理 办法》《上海证券交易所科创板股票上市规则》等有关法律、法规和规范性文件的规 定，不会导致公司实际控制人发生变化，不会导致公司主要业务结构发生变化，不会 引起公司管理层变动，不会对公司日常经营活动产生不利影响，亦不存在损害公司及 其他股东利益，尤其是中小股东利益的情形。 本次公司股东解除一致行动关系事项，不涉及各股东持股数量和持股比例的变化，不 涉及向市场增持或者减持。 向天津经济技术开发区市场监督管理局提交申请资料，并获得天津经济技术开发区市场 监督管理局颁发的《营业执照》，经阳光德业、阳光永业、阳光广业、阳光福业全体合伙 人一致同意，分别将原有限合伙人崔丽野先生 ...

Core Viewpoint - Sino Medical announced that its actual controller, Sun Jianhua, has terminated the concerted action relationship with Tianjin Sunshine Deye Enterprise Management Partnership (Limited Partnership) and three other companies, resulting in a reduction of his controlled shareholding in Sino Medical from 24.36% to 19.32%, a decrease of 5.05% [1] Summary by Relevant Sections - Shareholding Change - Sun Jianhua's controlled shares decreased to 80.3704 million shares, representing 19.32% of the total share capital [1] - The reduction in shareholding is attributed to the termination of the concerted action relationship with four companies [1] - Future Plans - As of the date of the report, there are no plans for Sun Jianhua to increase or decrease his shareholding in the company over the next 12 months [1]

Core Viewpoint - Sino Medical announced that its actual controller, Sun Jianhua, signed a "Consistent Action Termination Agreement" on October 17, 2025, with several companies, resulting in a reduction of his shareholding from 101 million shares (24.3641%) to 80.3704 million shares (19.3156%) [1] Summary by Relevant Sections - Shareholding Changes - Sun Jianhua's shareholding decreased from 101 million shares to 80.3704 million shares, representing a drop of approximately 4.048 million shares [1] - The percentage of shares held by Sun Jianhua decreased from 24.3641% to 19.3156% [1] - Control and Ownership - The change in shareholding does not involve any increase or decrease in shares, nor does it lead to a change in the company's controlling shareholder or actual controller [1] - The number of shares held directly and indirectly by the information disclosure obligor remains unchanged [1]

Market Overview - The medical device sector increased by 0.72% on October 15, with TuoJing Life leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Top Performers - TuoJing Life (300642) closed at 25.85, up 10.38% with a trading volume of 294,900 shares and a transaction value of 756 million [1] - JiMin Health (603222) closed at 10.97, up 10.03% with a trading volume of 353,400 shares [1] - MaiLanDe (688273) closed at 43.90, up 9.75% with a trading volume of 47,500 shares [1] - KeFu Medical (301087) closed at 43.10, up 7.86% with a trading volume of 72,700 shares [1] - Rejing Bio (688068) closed at 170.79, up 6.96% with a trading volume of 34,700 shares [1] Underperformers - JinHao Medical (920925) closed at 34.05, down 3.81% with a trading volume of 15,400 shares [2] - DaBo Medical (002901) closed at 55.52, down 2.94% with a trading volume of 29,400 shares [2] - HuaDa ZhiZao (688114) closed at 68.57, down 2.93% with a trading volume of 52,400 shares [2] Capital Flow - The medical device sector saw a net inflow of 500 million in main funds, while retail investors experienced a net outflow of 214 million [2][3] - Major stocks like SaiNuo Medical (688108) had a net inflow of 129 million from main funds, while JiMin Health (603222) saw a net outflow of 471 million from retail investors [3]

Market Overview - The medical device sector experienced a decline of 0.96% on October 14, with Hualan Co. leading the drop [1] - The Shanghai Composite Index closed at 3865.23, down 0.62%, while the Shenzhen Component Index closed at 12895.11, down 2.54% [1] Top Performers - Yingke Medical (300677) saw a significant increase of 12.69%, closing at 43.52 with a trading volume of 463,500 shares and a turnover of 1.963 billion [1] - Zhend Medical (603301) rose by 9.02%, closing at 65.89 with a trading volume of 151,400 shares and a turnover of 980 million [1] - Other notable gainers include JinHao Medical (920925) up 5.80%, Jiuan Medical (002432) up 4.06%, and Canar Co. (301122) up 3.47% [1] Underperformers - Hualan Co. (301093) fell by 6.45%, closing at 37.26 with a trading volume of 40,800 shares and a turnover of 157 million [2] - Aohua Endoscopy (688212) decreased by 5.64%, closing at 48.20 with a trading volume of 32,100 shares and a turnover of 159 million [2] - Other significant declines include Maike Aodi (300341) down 4.00% and Huachuang Technology (688151) down 3.57% [2] Capital Flow - The medical device sector saw a net outflow of 173 million from institutional investors, while retail investors experienced a net inflow of 69.34 million [2] - The sector's capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Sainuo Medical (688108) had a net inflow of 23.6 million from institutional investors, but a net outflow of 21.46 million from retail investors [3] - Yingke Medical (300677) experienced a net inflow of 96.89 million from institutional investors, with retail investors seeing a net outflow of 61.25 million [3] - Jiuan Medical (002432) had a net inflow of 39.29 million from institutional investors, while retail investors had a net inflow of 16.09 million [3]

格隆汇10月14日丨赛诺医疗(688108.SH)公布，公司于2025年10月13日收到郭彦超先生出具的《关于减 持赛诺医疗科学技术股份有限公司股份结果暨权益变动的告知函》，截至2025年10月13日收盘，郭彦超 先生通过大宗交易方式减持公司股份16.8万股，占公司目前总股本的0.04%，本次减持计划已实施完 毕。 ...

● 大股东持股的基本情况 本次股份减持计划实施前，赛诺医疗科学技术股份有限公司（以下简称"赛诺医疗"或"公司"）股东郭彦 超先生合计持有公司20,840,854股，占公司股份总数的5.01%。上述股份中20,500,000股为郭彦超先生于 2024年1月通过协议转让方式受让所得，该部分股份占当时公司股份总数的4.93%；上述股份中340,854 股为郭彦超先生通过二级市场集中竞价方式买入股份，该部分股份占公司股份总数的0.08%。 ● 减持计划的实施结果情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688108 证券简称：赛诺医疗 公告编号：2025-046 赛诺医疗科学技术股份有限公司 股东减持股份结果暨权益变动的提示性公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司于2025年10月13日收到郭彦超先生出具的《关于减持赛诺医疗科学技术股份有限公司股份结果暨权 益变动的告知函》，截至2025年10月13日收盘，郭彦超先生通过大宗交易方式减持公司股份168,000 股 ...

Trading Information - As of October 13, 2025, Sino Medical (688108) closed at 27.85 CNY, up 0.69% with a turnover rate of 4.83% and a trading volume of 200,800 lots, totaling a transaction amount of 549 million CNY [1] - On the same day, the net outflow of main funds was 6.86 million CNY, accounting for 1.25% of the total transaction amount; retail funds had a net inflow of 4.21 million CNY, accounting for 0.77% [1][5] Block Trading - On October 13, Sino Medical executed a block trade worth 4.6788 million CNY [2] Shareholder Changes - On October 13, shareholder Guo Yanchao reduced his holdings by 168,000 shares through a block trade, representing 0.0404% of the company's total share capital. Post-reduction, his holdings decreased to 20,672,854 shares, or 4.97% of the total [3] - The reduction occurred while the company's stock price increased by 0.69%, closing at 27.85 CNY [3] - Guo Yanchao's reduction was due to personal financial needs, and he had previously reduced his holdings by 1,930,000 shares from July 21 to July 22, 2025, which was 0.46% of the total share capital [3] - Guo Yanchao has no plans for further increases or reductions in the next 12 months [3][5]

赛诺医疗10月13日大宗交易平台出现一笔成交，成交量16.80万股，成交金额467.88万元，大宗交易成交 价为27.85元。该笔交易的买方营业部为东亚前海证券有限责任公司北京分公司，卖方营业部为国泰海 通证券股份有限公司蚌埠中荣街证券营业部。 成交量 （万 股） 成交金 额 （万 元） 成交价 格 （元） 相对当 日 收盘折 溢价 （%） 买方营业部 卖方营业部 16.80 467.88 27.85 0.00 东亚前海证券有限责任公司北 京分公司 国泰海通证券股份有限公司蚌埠中荣街 证券营业部 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 两融数据显示，该股最新融资余额为8.82亿元，近5日增加4295.08万元，增幅为5.12%。（数据宝） 10月13日赛诺医疗大宗交易一览 证券时报•数据宝统计显示，赛诺医疗今日收盘价为27.85元，上涨0.69%，日换手率为4.83%，成交额为 5.49亿元，全天主力资金净流出638.11万元，近5日该股累计上涨4.90%，近5日资金合计净流入5224.05 万元。 ...

证券代码：688108 证券简称：赛诺医疗 公告编号：2025-046 赛诺医疗科学技术股份有限公司 公司于 2025 年 10 月 13 日收到郭彦超先生出具的《关于减持赛诺医疗科学技术股份有限 公司股份结果暨权益变动的告知函》，截至 2025 年 10 月 13 日收盘，郭彦超先生通过大宗交易 方式减持公司股份 168,000 股，占公司目前总股本的 0.04%，本次减持计划已实施完毕。 | 股东名称 | 郭彦超 | | | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 □否 | | | 直接持股 5%以上股东 | √是 □否 | | | 董事、监事和高级管理人员 | □是 □否 | | | 其他： | | | 持股数量 | 20,840,854股 | | | 持股比例 | 5.01% | | | 当前持股股份来源 | 协议转让取得：20,500,000股 | | 一、减持主体减持前基本情况 1 集中竞价交易取得：340,854股 股东减持股份结果暨权益变动的提示性公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗 ...